Condition 1: Metabolic syndrome. Condition 2: Non-surgical periodontal treatment. Condition 3: Chronic periodontitis. Metabolic syndrome Chronic periodontitis
Conditions
Interventions
Intervention 1: Intervention group:The intervention group treatment is built on oral health education and non-surgical periodontal therapy.The oral health educations content consists brushing techniqu
Sponsors
Gorgan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients with 1st or 2nd Stage of periodontitis Ages between 35 to 60 Definitive metabolic syndrome diagnosis in both groups Having at least 20 teeth Consent for participation
Exclusion criteria
Exclusion criteria: Having any kind of disease that could effect periodontal tissue other than matabolic syndrome like: Papillon-lefevre? Treacher Collins? Aggressive periodontitis? AIDS and End Stage Renal Disease Taking any medication that could effect periodontal tissue such as: Nifedipine and Phenytoin Using orthodontic treatments or fixed long span prostheses or removable prostheses Taking Anti-biotics? Immunosuppressive drugs or Non-steroidal anti-inflammatory drugs for one week in last six month Using periodontal treatment in last six month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar factor value in blood test. Timepoint: Measuring the level of fasting blood sugar before the intervention and 3 and 6 months after the end of intervention. Method of measurement: Glucometer.;Triglycerides factor value in blood test. Timepoint: Measuring the level of triglyceride before the intervention and 3 and 6 months after the end of intervention. Method of measurement: Triglyceride Oxidase method.;Cholesterol factor value in blood test. Timepoint: Measuring the level of cholesterol before the intervention and 3 and 6 months after the end of intervention. Method of measurement: Cholesterol Oxidase method.;HDL factor value in blood test. Timepoint: Measuring the level of HDL before the intervention and 3 and 6 months after the end of intervention. Method of measurement: Enzymatic method.;Abdominal obesity in centimeters. Timepoint: Measuring the level of abdominal obesity before the intervention and 3 and 6 months after the end of intervention. Method of measurement: Tape measure.;Blood pressure. Timepoint: Measuring Blood pressure before the intervention and 3 and 6 months after the end of intervention. Method of measurement: Mercury sphygmomanometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Gingival recession. Timepoint: Measuring the amount of gingival recession before the intervention and 3 and 6 months after the end of the intervention. Method of measurement: Williams periodontal probe.;Clinical Attachment Loss. Timepoint: Measurement of clinical attachment loss before intervention and 3 and 6 months after the end of intervention. Method of measurement: Williams periodontal probe.;Pocket probing depth. Timepoint: Measurement of pocket probe depth before intervention and 3 and 6 months after the end of intervention. Method of measurement: Williams periodontal probe.;Plaque index. Timepoint: Measurement of plaque index before intervention and 3 and 6 months after the end of intervention. Method of measurement: Silness & Loe index.;Bleeding on probing. Timepoint: Measurement of bleeding on probing before the intervention and 3 and 6 months after the end of the intervention. Method of measurement: Williams periodontal probe. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir reza Ahmadinia
Gorgan University of Medical Sciences
Outcome results
None listed